VACCINE manufacturer CSL has
reported a $10m drop in its year on
year net profits to $1.05 billion from
$1.15 billion for the period to June.
Moving forward the company has
said that it expects its 2011 net profits
to be between $980m and $1.03b.
Although slightly less than 2009/
10, this represents a growth of up
to (around) 10 per cent on the
underlying operational profit,
largely reflecting CSL’s global
plasma therapeutics business,
which is expected to deliver this
growth,” CSL said in a statement.The above article was sent to subscribers in Pharmacy Daily's issue from 18 Aug 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Aug 10
STRONG growth in Australia has helped MedAdvisor Solutions achieve robust results for FY24, with a revenue increase of 24.6% on the previous corresponding period to $122.1 million.
WESFARMERS has today reported strong growth in revenue across its Health division and its Australian Pharmaceutical Industries (API) subsidiary, despite a significant reduction in COVID-19 anti-viral product sales.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.